KRIYA RARE DISEASE Trademark
Trademark Overview
On Tuesday, January 11, 2022, a trademark application was filed for KRIYA RARE DISEASE with the United States Patent and Trademark Office. The USPTO has given the KRIYA RARE DISEASE trademark a serial number of 97213564. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 1, 2024. This trademark is owned by Kriya Therapeutics, Inc.. The KRIYA RARE DISEASE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders
Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders
General Information
| Serial Number | 97213564 |
| Word Mark | KRIYA RARE DISEASE |
| Filing Date | Tuesday, January 11, 2022 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, January 1, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 4, 2022 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders |
| NOT AVAILABLE | "RARE DISEASE" |
| Goods and Services | Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 20, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 20, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Kriya Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Palo Alto, CA 94306 |
| Party Name | Kriya Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Redwood City, CA 94065 |
Trademark Events
| Event Date | Event Description |
| Friday, January 14, 2022 | NEW APPLICATION ENTERED |
| Thursday, January 20, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, July 21, 2022 | ASSIGNED TO EXAMINER |
| Monday, August 1, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, August 1, 2022 | NON-FINAL ACTION E-MAILED |
| Monday, August 1, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, August 30, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, August 30, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, August 30, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, August 30, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, August 30, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 14, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 4, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 4, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 29, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, March 10, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, March 10, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, March 10, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, May 2, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, May 2, 2023 | SOU EXTENSION 1 FILED |
| Tuesday, May 2, 2023 | SOU EXTENSION 1 GRANTED |
| Thursday, May 4, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, January 1, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, January 2, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
